New Yale study evaluates PAXLOVID's use in Long COVID recovery
NEW HAVEN, Conn., March 21, 2023. Yale School of Medicine announces the initiation of a novel, randomized trial that will test whether receiving PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) for 15 days can improve the health of highly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 21, 2023 Category: Pharmaceuticals Source Type: clinical trials
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
Conditions: Total Knee Replacement; Knee Arthroplasty Interventions: Drug: Bupivacaine-Liposomal Bupivacaine; Drug: Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate Sponsors: Yale University; Department of Anesthesiology Faculty Development Fund Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial
This study is designed to evaluate the clinical equivalence between Jiu-Wei-Xi-Feng granules (Os Draconis replaced byConcha Ostreae) (JWXFD) and Jiu-Wei-Xi-Feng granules (original formula) (JWXFO) in children with TD (consumption of renal yin and liver wind stirring up internally syndrome).Methods/designThis is a multicenter, randomized, double-blind, equivalence trial comparing the efficacy and safety of JWXFD and JWXFO in treating Children with tic disorders (consumption of renal yin and liver wind stirring up internally syndrome). A total of 288 patients will be recruited and randomly assigned to two groups in a 1:1 rat...
Source: Trials - October 22, 2022 Category: Research Source Type: clinical trials
